- Home
- HKD vs IMTX Comparison
HKD vs IMTX Comparison
Compare HKD & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKD
- IMTX
- Stock Information
- Founded
- HKD 2003
- IMTX N/A
- Country
- HKD France
- IMTX Germany
- Employees
- HKD N/A
- IMTX N/A
- Industry
- HKD Finance: Consumer Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HKD Finance
- IMTX Health Care
- Exchange
- HKD Nasdaq
- IMTX Nasdaq
- Market Cap
- HKD 656.8M
- IMTX 653.9M
- IPO Year
- HKD 2022
- IMTX N/A
- Fundamental
- Price
- HKD $1.84
- IMTX $6.56
- Analyst Decision
- HKD
- IMTX Strong Buy
- Analyst Count
- HKD 0
- IMTX 4
- Target Price
- HKD N/A
- IMTX $14.67
- AVG Volume (30 Days)
- HKD 228.8K
- IMTX 399.9K
- Earning Date
- HKD 01-01-0001
- IMTX 08-12-2025
- Dividend Yield
- HKD N/A
- IMTX N/A
- EPS Growth
- HKD 9.93
- IMTX N/A
- EPS
- HKD 0.23
- IMTX N/A
- Revenue
- HKD $20,445,000.00
- IMTX $155,801,989.00
- Revenue This Year
- HKD N/A
- IMTX N/A
- Revenue Next Year
- HKD N/A
- IMTX $1.92
- P/E Ratio
- HKD $8.03
- IMTX N/A
- Revenue Growth
- HKD N/A
- IMTX 93.56
- 52 Week Low
- HKD $1.65
- IMTX $3.30
- 52 Week High
- HKD $5.80
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- HKD 50.19
- IMTX 66.69
- Support Level
- HKD $1.77
- IMTX $5.70
- Resistance Level
- HKD $1.84
- IMTX $6.57
- Average True Range (ATR)
- HKD 0.07
- IMTX 0.33
- MACD
- HKD 0.02
- IMTX 0.05
- Stochastic Oscillator
- HKD 70.59
- IMTX 99.50
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.